Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.84
+0.04000.69%
Post-market: 5.880.0400+0.68%19:34 EST
Volume:1.27M
Turnover:7.47M
Market Cap:316.44M
PE:-1.47
High:6.10
Open:5.65
Low:5.61
Close:5.80
Loading ...

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Jan

Emergent BioSolutions: Strong Buy Rating Driven by Government Contracts and Growth in Medical Countermeasures

TIPRANKS
·
10 Jan

Those who invested in Emergent BioSolutions (NYSE:EBS) a year ago are up 365%

Simply Wall St.
·
09 Jan

Emergent BioSolutions Receives $20 Million Contract to Supply Anthrax Vaccine to US Military

MT Newswires Live
·
09 Jan

BRIEF-Emergent Biosolutions Announces Exercise Of $20 Million Option To Supply U.S. Department Of Defense With Biothrax

Reuters
·
08 Jan

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

GlobeNewswire
·
08 Jan

Emergent BioSolutions exercises $20M option to supply DoD with BioThrax

TIPRANKS
·
08 Jan

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense With Biothrax® (Anthrax Vaccine Adsorbed)

THOMSON REUTERS
·
08 Jan

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

GlobeNewswire
·
08 Jan

Emergent BioSolutions rises 5.3%

TIPRANKS
·
31 Dec 2024

Why Emergent BioSolutions Stock Blasted Higher Today

Motley Fool
·
31 Dec 2024

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
31 Dec 2024

Sector Update: Health Care Stocks Lower Monday Afternoon

MT Newswires Live
·
31 Dec 2024

Crude Oil Gains 1%; Chicago PMI Falls In December

Benzinga
·
31 Dec 2024

Emergent BioSolutions Shares Rise After HC Wainwright Begins Coverage With Buy Rating

MT Newswires Live
·
31 Dec 2024

HC Wainwright Initiates Emergent BioSolutions at Buy With $15 Price Target

MT Newswires Live
·
30 Dec 2024